How have DXTRQ shares performed in 2024?

Dex Liquidating's stock was trading at $0.0331 at the beginning of the year. Since then, DXTRQ stock has decreased by 9.4% and is now trading at $0.03. View the best growth stocks for 2024 here .

How do I buy shares of Dex Liquidating?

Shares of DXTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:DXTRQ

Dex Liquidating (DXTRQ) Stock Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)

Free DXTRQ Stock Alerts

$0.03

0.00 (0.00%)

(As of 12/4/2018)

Compare

Today's Range: $0.03
▼
$0.03
50-Day Range: $0.03
▼
$0.03
52-Week Range: $0.02
▼
$0.16

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Dex Liquidating alerts:

Ad Traders Agency

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

About Dex Liquidating

Dextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company's product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California.

DXTRQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DXTRQ Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive DXTRQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dex Liquidating and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/23/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:DXTRQ
CUSIP: N/A
CIK: N/A
Web: www.dexterasurgical.com
Phone: 650-364-9975
Fax: 650-364-3134
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Competitors

View All Competitors

DXTRQ Stock Analysis - Frequently Asked Questions

How have DXTRQ shares performed in 2024?: Dex Liquidating's stock was trading at $0.0331 at the beginning of the year. Since then, DXTRQ stock has decreased by 9.4% and is now trading at $0.03.
View the best growth stocks for 2024 here.
How do I buy shares of Dex Liquidating?: Shares of DXTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DXTRQ) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial